In October 2024, Omron Healthcare received de novo authorisation from the US Food and Drugs Administration (FDA) to market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback